Raj Reddy
Chief Executive Officer Canary Cure
Raj is a biotechnology pioneer and the President and CEO of Canary Cure, a leading gene and RNA therapy company developing RNA therapies for the treatment of metabolic, obesity and rare genetic diseases. He has over 10 years of experience in leading and scaling biotech ventures, with a background in pharmacology and medicinal chemistry as well as a track record of innovation and excellence in RNA therapeutics and diagnostics. He has a special focus in the metabolic genetics. Raj has over 20 patents filed in Genetics and RNA therapy. Raj believes that understanding the genetic underpinnings of diseases and harnessing the power of RNA can unlock new frontiers in precision medicine. By targeting mechanistic systems and genetics, he aims to revolutionize healthcare and create a world where diseases are detected earlier and treated more effectively.
Seminars
- Examine emerging metabolic pathways beyond GLP-1 approaches
- Explore advances in adipocyte-specific delivery technologies
- Enable transformative therapies for obesity and metabolic disease
- Learn from companies advancing through late-stage development
- Identify recurring challenges and successful solutions
- Apply practical insights to accelerate program progression
